[VRDN] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
11-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -106.12%
YoY- 68.10%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 1,195 256 216 214 208 1,090 1,451 -12.12%
PBT -28,905 -29,491 -25,693 -28,946 -14,043 -17,964 -18,460 34.80%
Tax -880 227 -196 3 91 9 55 -
NP -28,025 -29,491 -25,497 -28,946 -14,043 -17,964 -18,460 32.05%
Tax Rate - - - - - - - -
Total Cost 29,220 29,747 25,713 29,160 14,251 19,054 19,911 29.10%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -2,345.19 -11,519.92 -11,804.17 -13,526.17 -6,751.44 -1,648.07 -1,272.23 50.28%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.83 -1.06 -0.98 -2.59 -1.26 -2.22 -2.91 -56.63%
EPS Diluted -0.83 -1.06 -0.98 -2.59 -1.26 -2.22 -2.91 -56.63%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.